FDA Turns Off Otsuka’s Abilify Dimmer Switch Graphic

As lights go out on the franchise, FDA says pharmacology aid misleadingly suggests Abilify offers advantages over other treatments.

More from Post-Marketing Regulation & Studies

More from Product Reviews